Retractable Technologies Total Depreciation and Amortization - Cash Flow 2010-2024 | RVP
Retractable Technologies total depreciation and amortization - cash flow from 2010 to 2024. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
| Retractable Technologies Annual Total Depreciation and Amortization - Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $8 |
| 2023 | $8 |
| 2022 | $5 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $1 |
| 2018 | $1 |
| 2017 | $1 |
| 2016 | $1 |
| 2015 | $1 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $1 |
| 2011 | $1 |
| 2010 | $2 |
| 2009 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.000B | $0.033B |
| Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $86.050B | 20.78 |
| Becton Dickinson (BDX) | United States | $50.254B | 12.44 |
| Cardinal Health (CAH) | United States | $35.386B | 18.53 |
| Straumann Holding AG (SAUHY) | Switzerland | $21.670B | 0.00 |
| Labcorp (LH) | United States | $20.926B | 16.97 |
| Cooper (COO) | United States | $16.350B | 21.69 |
| West Pharmaceutical Services (WST) | United States | $15.509B | 32.51 |
| Align Technology (ALGN) | United States | $13.803B | 27.40 |
| Henry Schein (HSIC) | United States | $8.586B | 14.73 |
| Merit Medical Systems (MMSI) | United States | $5.769B | 27.89 |
| DENTSPLY SIRONA (XRAY) | United States | $3.308B | 9.88 |
| CONMED (CNMD) | United States | $1.858B | 13.90 |
| STAAR Surgical (STAA) | United States | $0.941B | 0.00 |
| Lifevantage (LFVN) | United States | $0.153B | 15.75 |
| Pro-Dex (PDEX) | United States | $0.139B | 15.18 |